The Invida consumer health portfolio is composed of brands that are marketed in the main segments of the consumer health category, including cold & flu, antacid and analgesics as well as many other products. In addition, new launches will move Invida into growth areas of consumer health such as natural supplements supported with clinical evidence.

Dermatix®
Dermatix® is a first line, non-invasive treatment intended to reduce the impact of unwanted scarring.  It is clinically proven to soften, flatten and smooth scars, and relieve the itching and discomfort associated with them.

The unique formulation of Dermatix® has significant advantages over other scar therapies in terms of efficacy and convenience. Dermatix® is effective for the treatment and prevention of hypertrophic and keloid scars and has also been successfully used to manage scars resulting from trauma, burns and surgery.

Dermatix® is available in most Asian markets, including China where it received regulatory approval in October 2009.

OmegaGen® Cardio
OmegaGen® Cardio is a natural highly concentrated Omega-3 supplement, sold over-the-counter and supported with clinical evidence in lowering cholesterol. It’s the first brand of its type launched in Australia with growing support among General Practioners. OMEGAGEN Cardio is currently marketed in Australia and New Zealand.

Breacol®
Breacol® is a range of cough and cold medications currently marketed in Malaysia, Singapore, and Hong Kong.

Actal®
Actal® is a fast-acting antacid to relieve gastric pain, heartburn and stomach upset and is marketed in a number of countries including Hong Kong, Singapore and Malaysia.